COL4A5 and cardiac arrhythmia: Notably, we demonstrate that treatment with flecainide, a drug that is used to treat arrhythmias in patients with ATS54–56, substantially exacerbates the ATS1 phenotype and leads to both reentrant and multifocal arrhythmia mechanisms in the mouse model.